Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disorders

Atsushi Matsumoto, Tomoyuki Tahara, Haruhiko Morita, Kensuke Usuki, Hideya Ohashi, Atsuko Kokubo-Watarai, Kieko Takahashi, Eiko Shimizu, Hikaru Tsunakawa, Kinya Ogami, Hiroshi Miyazaki, Akio Urabe, Takashi Kato

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Thrombopoietin (TPO) isolated from thrombocytopenic plasma of various animal species has previously been shown to comprise only truncated forms of the molecule, presumably generated by proteolysis. Native TPO has now been partially purified from normal human plasma by immunoaffinity chromatography and was confirmed to be biologically active. Gel filtration in the presence of SDS revealed that TPO eluted in two peaks: a major peak corresponding to the elution position of fully glycosylated recombinant human TPO (rhTPO) consisting of 332 amino acid residues, and a minor peak corresponding to a smaller molecular size. Immunoblot analysis also revealed that most plasma-derived TPO migrated at the same position as fully gly- cosylated rhTPO, corresponding to molecular size of ~ 80 to 100 kDa. Furthermore, the size distribution of circulating TPO in patients with various haematologic disorders did not differ markedly from that of plasma-derived TPO from healthy individuals. These results indicate that the truncation of circulating TPO is not related to disease pathophysiology, and that the predominant form of TPO in blood is a biologically active ~ 80- to 100-kDa species. The size distribution of TPO extracted from normal platelets was similar to that of TPO in plasma; the proportion of truncated TPO was decreased by prior incubation of platelets with hirudin, indicating that the endogenous truncated TPO, at least in platelet extract, was generated by thrombin-mediated cleavage.

Original languageEnglish
Pages (from-to)24-29
Number of pages6
JournalThrombosis and Haemostasis
Volume82
Issue number1
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Thrombopoietin
Population Groups
Blood Platelets
Hirudins
Thrombin
Proteolysis
Gel Chromatography
Chromatography

ASJC Scopus subject areas

  • Hematology

Cite this

Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disorders. / Matsumoto, Atsushi; Tahara, Tomoyuki; Morita, Haruhiko; Usuki, Kensuke; Ohashi, Hideya; Kokubo-Watarai, Atsuko; Takahashi, Kieko; Shimizu, Eiko; Tsunakawa, Hikaru; Ogami, Kinya; Miyazaki, Hiroshi; Urabe, Akio; Kato, Takashi.

In: Thrombosis and Haemostasis, Vol. 82, No. 1, 1999, p. 24-29.

Research output: Contribution to journalArticle

Matsumoto, A, Tahara, T, Morita, H, Usuki, K, Ohashi, H, Kokubo-Watarai, A, Takahashi, K, Shimizu, E, Tsunakawa, H, Ogami, K, Miyazaki, H, Urabe, A & Kato, T 1999, 'Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disorders', Thrombosis and Haemostasis, vol. 82, no. 1, pp. 24-29.
Matsumoto, Atsushi ; Tahara, Tomoyuki ; Morita, Haruhiko ; Usuki, Kensuke ; Ohashi, Hideya ; Kokubo-Watarai, Atsuko ; Takahashi, Kieko ; Shimizu, Eiko ; Tsunakawa, Hikaru ; Ogami, Kinya ; Miyazaki, Hiroshi ; Urabe, Akio ; Kato, Takashi. / Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disorders. In: Thrombosis and Haemostasis. 1999 ; Vol. 82, No. 1. pp. 24-29.
@article{b261c4c52d384cafa972fe34faf70c05,
title = "Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disorders",
abstract = "Thrombopoietin (TPO) isolated from thrombocytopenic plasma of various animal species has previously been shown to comprise only truncated forms of the molecule, presumably generated by proteolysis. Native TPO has now been partially purified from normal human plasma by immunoaffinity chromatography and was confirmed to be biologically active. Gel filtration in the presence of SDS revealed that TPO eluted in two peaks: a major peak corresponding to the elution position of fully glycosylated recombinant human TPO (rhTPO) consisting of 332 amino acid residues, and a minor peak corresponding to a smaller molecular size. Immunoblot analysis also revealed that most plasma-derived TPO migrated at the same position as fully gly- cosylated rhTPO, corresponding to molecular size of ~ 80 to 100 kDa. Furthermore, the size distribution of circulating TPO in patients with various haematologic disorders did not differ markedly from that of plasma-derived TPO from healthy individuals. These results indicate that the truncation of circulating TPO is not related to disease pathophysiology, and that the predominant form of TPO in blood is a biologically active ~ 80- to 100-kDa species. The size distribution of TPO extracted from normal platelets was similar to that of TPO in plasma; the proportion of truncated TPO was decreased by prior incubation of platelets with hirudin, indicating that the endogenous truncated TPO, at least in platelet extract, was generated by thrombin-mediated cleavage.",
author = "Atsushi Matsumoto and Tomoyuki Tahara and Haruhiko Morita and Kensuke Usuki and Hideya Ohashi and Atsuko Kokubo-Watarai and Kieko Takahashi and Eiko Shimizu and Hikaru Tsunakawa and Kinya Ogami and Hiroshi Miyazaki and Akio Urabe and Takashi Kato",
year = "1999",
language = "English",
volume = "82",
pages = "24--29",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "1",

}

TY - JOUR

T1 - Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disorders

AU - Matsumoto, Atsushi

AU - Tahara, Tomoyuki

AU - Morita, Haruhiko

AU - Usuki, Kensuke

AU - Ohashi, Hideya

AU - Kokubo-Watarai, Atsuko

AU - Takahashi, Kieko

AU - Shimizu, Eiko

AU - Tsunakawa, Hikaru

AU - Ogami, Kinya

AU - Miyazaki, Hiroshi

AU - Urabe, Akio

AU - Kato, Takashi

PY - 1999

Y1 - 1999

N2 - Thrombopoietin (TPO) isolated from thrombocytopenic plasma of various animal species has previously been shown to comprise only truncated forms of the molecule, presumably generated by proteolysis. Native TPO has now been partially purified from normal human plasma by immunoaffinity chromatography and was confirmed to be biologically active. Gel filtration in the presence of SDS revealed that TPO eluted in two peaks: a major peak corresponding to the elution position of fully glycosylated recombinant human TPO (rhTPO) consisting of 332 amino acid residues, and a minor peak corresponding to a smaller molecular size. Immunoblot analysis also revealed that most plasma-derived TPO migrated at the same position as fully gly- cosylated rhTPO, corresponding to molecular size of ~ 80 to 100 kDa. Furthermore, the size distribution of circulating TPO in patients with various haematologic disorders did not differ markedly from that of plasma-derived TPO from healthy individuals. These results indicate that the truncation of circulating TPO is not related to disease pathophysiology, and that the predominant form of TPO in blood is a biologically active ~ 80- to 100-kDa species. The size distribution of TPO extracted from normal platelets was similar to that of TPO in plasma; the proportion of truncated TPO was decreased by prior incubation of platelets with hirudin, indicating that the endogenous truncated TPO, at least in platelet extract, was generated by thrombin-mediated cleavage.

AB - Thrombopoietin (TPO) isolated from thrombocytopenic plasma of various animal species has previously been shown to comprise only truncated forms of the molecule, presumably generated by proteolysis. Native TPO has now been partially purified from normal human plasma by immunoaffinity chromatography and was confirmed to be biologically active. Gel filtration in the presence of SDS revealed that TPO eluted in two peaks: a major peak corresponding to the elution position of fully glycosylated recombinant human TPO (rhTPO) consisting of 332 amino acid residues, and a minor peak corresponding to a smaller molecular size. Immunoblot analysis also revealed that most plasma-derived TPO migrated at the same position as fully gly- cosylated rhTPO, corresponding to molecular size of ~ 80 to 100 kDa. Furthermore, the size distribution of circulating TPO in patients with various haematologic disorders did not differ markedly from that of plasma-derived TPO from healthy individuals. These results indicate that the truncation of circulating TPO is not related to disease pathophysiology, and that the predominant form of TPO in blood is a biologically active ~ 80- to 100-kDa species. The size distribution of TPO extracted from normal platelets was similar to that of TPO in plasma; the proportion of truncated TPO was decreased by prior incubation of platelets with hirudin, indicating that the endogenous truncated TPO, at least in platelet extract, was generated by thrombin-mediated cleavage.

UR - http://www.scopus.com/inward/record.url?scp=0032767652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032767652&partnerID=8YFLogxK

M3 - Article

VL - 82

SP - 24

EP - 29

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 1

ER -